199 related articles for article (PubMed ID: 12237533)
1. Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera.
Morita Y; Tsushima Y; Yasui M; Termoz R; Ajioka J; Takayama K
Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1181-6. PubMed ID: 12237533
[TBL] [Abstract][Full Text] [Related]
2. Disintegration propensity of tablets evaluated by means of disintegrating force kinetics.
Massimo G; Catellani PL; Santi P; Bettini R; Vaona G; Bonfanti A; Maggi L; Colombo P
Pharm Dev Technol; 2000; 5(2):163-9. PubMed ID: 10810746
[TBL] [Abstract][Full Text] [Related]
3. Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet.
Hazdi SN; Phang HC; Ng ZQ; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
Int J Pharm Compd; 2023; 27(6):522-527. PubMed ID: 38100670
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
Bi Y; Sunada H; Yonezawa Y; Danjo K; Otsuka A; Iida K
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2121-7. PubMed ID: 8945778
[TBL] [Abstract][Full Text] [Related]
5. The preparation of orally disintegrating tablets using a hydrophilic waxy binder.
Abdelbary G; Prinderre P; Eouani C; Joachim J; Reynier JP; Piccerelle P
Int J Pharm; 2004 Jul; 278(2):423-33. PubMed ID: 15196646
[TBL] [Abstract][Full Text] [Related]
6. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
Brniak W; Jachowicz R; Krupa A; Skorka T; Niwinski K
Pharm Dev Technol; 2013; 18(2):464-74. PubMed ID: 22881600
[TBL] [Abstract][Full Text] [Related]
8. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
[TBL] [Abstract][Full Text] [Related]
9. Application of a novel automatic disintegration apparatus for the development and evaluation of a direct compression rapidly disintegrating tablet.
Jung HA; Augsburger LL
Drug Dev Ind Pharm; 2012 Jul; 38(7):825-36. PubMed ID: 22091970
[TBL] [Abstract][Full Text] [Related]
10. Development of fast disintegrating compressed tablets using amino acid as disintegration accelerator: evaluation of wetting and disintegration of tablet on the basis of surface free energy.
Fukami J; Ozawa A; Yoshihashi Y; Yonemochi E; Terada K
Chem Pharm Bull (Tokyo); 2005 Dec; 53(12):1536-9. PubMed ID: 16327184
[TBL] [Abstract][Full Text] [Related]
11. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration.
Abdelbary G; Eouani C; Prinderre P; Joachim J; Reynier J; Piccerelle P
Int J Pharm; 2005 Mar; 292(1-2):29-41. PubMed ID: 15725551
[TBL] [Abstract][Full Text] [Related]
12. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression.
Olmez SS; Vural I; Sahin S; Ertugrul A; Capan Y
Pharmazie; 2013 Feb; 68(2):110-6. PubMed ID: 23469682
[TBL] [Abstract][Full Text] [Related]
13. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
14. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
[TBL] [Abstract][Full Text] [Related]
15. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
[TBL] [Abstract][Full Text] [Related]
16. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder.
Mimura K; Kanada K; Uchida S; Yamada M; Namiki N
Chem Pharm Bull (Tokyo); 2011; 59(8):959-64. PubMed ID: 21804239
[TBL] [Abstract][Full Text] [Related]
17. Preparation of Loratadine Orally Disintegrating Tablets by Semi-solid Extrusion 3D Printing.
Yi S; Xie J; Chen L; Xu F
Curr Drug Deliv; 2023; 20(6):818-829. PubMed ID: 36221886
[TBL] [Abstract][Full Text] [Related]
18. Assessment of disintegration of rapidly disintegrating tablets by a visiometric liquid jet-mediated disintegration apparatus.
Desai PM; Liew CV; Heng PW
Int J Pharm; 2013 Feb; 442(1-2):65-73. PubMed ID: 22985772
[TBL] [Abstract][Full Text] [Related]
19. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
Kasliwal N; Negi JS; Jugran V; Jain R
Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel and simple method to evaluate disintegration of rapidly disintegrating tablets.
Hoashi Y; Tozuka Y; Takeuchi H
Chem Pharm Bull (Tokyo); 2013; 61(9):962-6. PubMed ID: 23995360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]